Related Experiment Video
Updated: Jan 27, 2026
07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
13.2K
NKG2D Polymorphism in Melanoma Patients from Southeastern Spain
Lourdes Gimeno1, Helios Martínez-Banaclocha2, M Victoria Bernardo3
1Immunology Service, Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA), Instituto Murciano de Investigación Biomédica (IMIB), 30120 Murcia, Spain. lourdes.gimeno@carm.es.
Cancers
|March 31, 2019
Summary
Genetic variations in the Natural Killer Cell Complex (NKC) region, specifically the NKG2D gene, are linked to an increased risk of developing cutaneous malignant melanoma. This finding may impact future melanoma risk assessment.
Area of Science:
- Immunology
- Genetics
- Oncology
Background:
- Natural killer (NK) and CD8+ T cells are crucial for anti-melanoma immune responses.
- C-Type lectin-like NK cell receptors, located in the Natural Killer Complex (NKC) region, regulate these immune cells.
- Previous studies indicated a link between NKC gene polymorphisms and cancer risk.
Purpose of the Study:
- To investigate the association between polymorphisms in the NKC region and the risk of cutaneous melanoma.
- To analyze specific single-nucleotide polymorphisms (SNPs) within the NKG2D gene and NKG2A promoter.
Main Methods:
- Genotyping of seven SNPs in the NKG2D gene and one SNP in the NKG2A promoter using a TaqMan 5' Nuclease Assay.
- Analysis included 233 melanoma patients and 200 healthy controls from southeastern Spain.
- Linkage disequilibrium and haplotype analyses were performed on the NKC region SNPs.
Main Results:
- Two haplotype blocks (Hb-1 and Hb-2) were identified in the NKC region.
- A specific haplotype (CAT, from block Hb-2-NK3) was significantly more frequent in melanoma patients compared to controls (p = 0.00009).
- No significant associations were found when individual NKC SNPs were analyzed independently.
Conclusions:
- The study suggests a significant association between NKG2D gene polymorphisms and the risk of cutaneous malignant melanoma.
- These findings highlight the potential role of NKC region genetic variations in melanoma susceptibility.
More Related Videos
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
18.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.0K
01:21Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
686
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
686
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
163
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
163
01:13Patient-centered Care
2.9K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.9K
01:21Drug Dosing: Obese Patients
238
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
238
01:15Drug Dosing: Geriatric Patients
229
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
229